Hajime Arahata

817 total citations
26 papers, 519 citations indexed

About

Hajime Arahata is a scholar working on Neurology, Molecular Biology and Genetics. According to data from OpenAlex, Hajime Arahata has authored 26 papers receiving a total of 519 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Neurology, 9 papers in Molecular Biology and 7 papers in Genetics. Recurrent topics in Hajime Arahata's work include Neurogenetic and Muscular Disorders Research (7 papers), Parkinson's Disease Mechanisms and Treatments (7 papers) and Genetic Neurodegenerative Diseases (7 papers). Hajime Arahata is often cited by papers focused on Neurogenetic and Muscular Disorders Research (7 papers), Parkinson's Disease Mechanisms and Treatments (7 papers) and Genetic Neurodegenerative Diseases (7 papers). Hajime Arahata collaborates with scholars based in Japan and United States. Hajime Arahata's co-authors include Yasunori Fujita, Yoshihiro Fukumoto, Toshio Kojima, Yasutoshi Koga, M. Tanaka, Akiko Ishii, Masafumi Ito, Tatsuyuki Kakuma, Shuichi Yatsuga and Hirokazu Furuya and has published in prestigious journals such as Annals of Neurology, Acta Neuropathologica and Journal of Neuropathology & Experimental Neurology.

In The Last Decade

Hajime Arahata

23 papers receiving 512 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hajime Arahata Japan 11 203 150 126 123 81 26 519
Cláudia Suemi Kamoi Kay Brazil 14 236 1.2× 294 2.0× 68 0.5× 92 0.7× 44 0.5× 70 624
Andrew J. Waclawik United States 11 232 1.1× 116 0.8× 49 0.4× 66 0.5× 42 0.5× 36 534
Robert‐Yves Carlier France 12 253 1.2× 68 0.5× 135 1.1× 155 1.3× 93 1.1× 37 546
Stefen Brady United Kingdom 15 356 1.8× 132 0.9× 50 0.4× 316 2.6× 116 1.4× 38 836
Keiko Ishigaki Japan 13 252 1.2× 68 0.5× 110 0.9× 64 0.5× 50 0.6× 58 476
Maria del Mar Amador France 11 133 0.7× 231 1.5× 33 0.3× 32 0.3× 96 1.2× 25 482
Shafeeq Ladha United States 11 132 0.7× 487 3.2× 67 0.5× 26 0.2× 221 2.7× 31 667
Hisashi Narai Japan 15 120 0.6× 312 2.1× 59 0.5× 81 0.7× 96 1.2× 47 580
Kalliopi Marinou Italy 12 170 0.8× 472 3.1× 99 0.8× 31 0.3× 189 2.3× 14 660
Lorenzo Peverelli Italy 11 229 1.1× 124 0.8× 51 0.4× 40 0.3× 85 1.0× 26 393

Countries citing papers authored by Hajime Arahata

Since Specialization
Citations

This map shows the geographic impact of Hajime Arahata's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hajime Arahata with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hajime Arahata more than expected).

Fields of papers citing papers by Hajime Arahata

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hajime Arahata. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hajime Arahata. The network helps show where Hajime Arahata may publish in the future.

Co-authorship network of co-authors of Hajime Arahata

This figure shows the co-authorship network connecting the top 25 collaborators of Hajime Arahata. A scholar is included among the top collaborators of Hajime Arahata based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hajime Arahata. Hajime Arahata is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Honda, Hiroyuki, et al.. (2023). Increased expression of human antiviral protein MxA in FUS proteinopathy in amyotrophic lateral sclerosis. Brain Pathology. 34(2). e13191–e13191. 2 indexed citations
2.
Umemoto, George, et al.. (2023). Factors that impact dysphagia and discontinuance of oral intake in patients with progressive supranuclear palsy. Frontiers in Neurology. 14. 1259327–1259327.
3.
Ogasawara, Masashi, Nobuyuki Eura, Utako Nagaoka, et al.. (2021). Intranuclear inclusions in skin biopsies are not limited to neuronal intranuclear inclusion disease but can also be seen in oculopharyngodistal myopathy. Neuropathology and Applied Neurobiology. 48(3). e12787–e12787. 14 indexed citations
4.
Umemoto, George, Shinsuke Fujioka, Hajime Arahata, et al.. (2021). Longitudinal Changes of Tongue Thickness and Tongue Pressure in Neuromuscular Disorders. BMC Neurology. 21(1). 302–302. 7 indexed citations
5.
Umemoto, George, Shinsuke Fujioka, Hajime Arahata, et al.. (2020). Relationship between tongue pressure and functional oral intake scale diet type in patients with neurological and neuromuscular disorders. Clinical Neurology and Neurosurgery. 198. 106196–106196. 8 indexed citations
6.
Fukae, Jiro, Shinsuke Fujioka, George Umemoto, et al.. (2020). Impact of Residual Drug in the Pharynx on the Delayed‐On Phenomenon in Parkinson's Disease Patients. Movement Disorders Clinical Practice. 7(3). 273–278. 13 indexed citations
7.
Mizuno, Yuri, Hideomi Hamasaki, Hajime Arahata, et al.. (2018). Four‐repeat tau dominant pathology in a congenital myotonic dystrophy type 1 patient with mental retardation. Brain Pathology. 28(3). 431–433. 3 indexed citations
8.
Umemoto, George, Hirokazu Furuya, Yoshio Tsuboi, et al.. (2017). Characteristics of tongue and pharyngeal pressure in patients with neuromuscular diseases. PubMed. Volume 7. 71–78. 13 indexed citations
9.
Umemoto, George, Yoshio Tsuboi, Hirokazu Furuya, et al.. (2017). Dysphagia in Perry Syndrome: Pharyngeal Pressure in Two Cases. Case Reports in Neurology. 9(2). 161–167. 2 indexed citations
10.
Arahata, Hajime, K Inada, Aya Miyoshi, et al.. (2017). Percutaneous endoscopic gastrostomy in patients with Duchenne muscular dystrophy compared with amyotrophic lateral sclerosis and Parkinson syndrome. Neuromuscular Disorders. 27. S102–S102. 1 indexed citations
11.
Yatsuga, Shuichi, Yasunori Fujita, Akiko Ishii, et al.. (2015). Growth differentiation factor 15 as a useful biomarker for mitochondrial disorders. Annals of Neurology. 78(5). 814–823. 206 indexed citations
12.
Arahata, Hajime, Yasumasa Ohyagi, Kyoko Iinuma, et al.. (2014). Early inhibition of tumor necrosis factor‐α and interleukin‐6 in muscle tissue as a therapy for dystrophinopathy in mdx mice. Clinical and Experimental Neuroimmunology. 5(3). 371–377.
13.
Shimizu, Toshio, Utako Nagaoka, Yuki Nakayama, et al.. (2012). Reduction rate of body mass index predicts prognosis for survival in amyotrophic lateral sclerosis: A multicenter study in Japan. Amyotrophic Lateral Sclerosis. 13(4). 363–366. 85 indexed citations
14.
Umemoto, George, et al.. (2012). Dysphagia in duchenne muscular dystrophy versus myotonic dystrophy type 1. Muscle & Nerve. 46(4). 490–495. 15 indexed citations
15.
Watanabe, Mitsuru, Hirofumi Ochi, Hajime Arahata, et al.. (2012). Myopathy in autoimmune polyendocrinopathy‐ candidiasis‐ectodermal dystrophy. Muscle & Nerve. 45(6). 904–908. 7 indexed citations
16.
17.
Ikezoe, Koji, Hirokazu Furuya, Hajime Arahata, et al.. (2009). Amyloid-β accumulation caused by chloroquine injections precedes ER stress and autophagosome formation in rat skeletal muscle. Acta Neuropathologica. 117(5). 575–582. 19 indexed citations
18.
Ikezoe, Koji, Masayuki Nakamori, Hirokazu Furuya, et al.. (2007). Endoplasmic reticulum stress in myotonic dystrophy type 1 muscle. Acta Neuropathologica. 114(5). 527–535. 46 indexed citations
19.
Murai, Hiroyuki, Hajime Arahata, Manabu Osoegawa, et al.. (2004). Effect of immunotherapy in myelitis with atopic diathesis. Journal of the Neurological Sciences. 227(1). 39–47. 12 indexed citations
20.
Arahata, Hajime, Kiyoshi Migita, Taiichiro Miyashita, et al.. (1999). Successful Treatment of Rapidly Progressive Lupus Nephritis Associated with Anti-MPO Antibodies by Intravenous Immunoglobulins. Clinical Rheumatology. 18(1). 77–81. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Cláudia Suemi Kamoi Kay Breakdown of academic impact, for papers by Andrew J. Waclawik Breakdown of academic impact, for papers by Robert‐Yves Carlier Breakdown of academic impact, for papers by Stefen Brady Breakdown of academic impact, for papers by Keiko Ishigaki Breakdown of academic impact, for papers by Maria del Mar Amador Breakdown of academic impact, for papers by Shafeeq Ladha Breakdown of academic impact, for papers by Hisashi Narai Breakdown of academic impact, for papers by Kalliopi Marinou Breakdown of academic impact, for papers by Lorenzo Peverelli
Rankless by CCL
2026